Luan

Quick links to important sections

Luan

Selected form

Medically reviewed

Laura Arias

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Luan

Luan is a medicinal preparation defined by its chemical composition and its action to induce localized numbness on the surface of the skin or mucous membranes. It is a highly focused single-ingredient product designed exclusively for topical administration.

Property Description
Active ingredient Lidocaine Hydrochloride
Form Cutaneous Spray Solution
Pharmacological class Local Anesthetic
Common purpose Alleviating localized pain and itching
Origin Synthetic

Defining Luan: What Type of Medicine is It?

Luan is classified pharmacologically as a local anesthetic, a substance that temporarily blocks sensation in a specific, limited area of the body. Its core constituent is the synthetic active ingredient Lidocaine Hydrochloride. Lidocaine is utilized for its properties as an anesthetic and its clinical application in providing localized numbness. Lidocaine is specifically categorized as an amide-type local anesthetic, which differentiates it chemically from older ester-type compounds.


Composition and Delivery: The Luan Cutaneous Spray Solution

The composition of the product utilizes Lidocaine Hydrochloride formulated within a pharmaceutical-grade solution base, typically aqueous or hydroalcoholic. Luan is presented as a cutaneous spray, a specialized dosage form facilitating contact-free and efficient application onto the target surface. This distinct spray presentation, designed for topical administration, ensures rapid dispersion of the active compound, enabling quick onset of its localized desensitizing effect. Lidocaine is a widely accepted agent for producing superficial anesthesia.


General Purpose of Luan: Alleviating Localized Discomfort

The general purpose of Luan is to provide effective, temporary management of acute localized discomfort that arises from heightened surface sensation. By inducing the state of surface anesthesia, the preparation directly targets peripheral nerve endings to interrupt sensory signals. This action is intended to offer specific pain relief and reduce intense irritative symptoms, such as severe pruritus (itching), in the area where the spray is applied, which is a key factor in its positioning for immediate symptomatic relief.

Regulatory References

  1. Lidocaine entry in eEML
  2. Lidocaine Topical MedlinePlus
  3. NIH MedlinePlus

What side effects are possible with Luan?

Possible Side Effects and Safety Information

The safety profile of Luan is formally documented by regulatory authorities, classifying potential effects based on frequency and affected body systems. The risk profile is characterized by a clear distinction between localized adverse reactions and rare, systemic toxicities resulting from excessive absorption of the active ingredient, Lidocaine.

Adverse Reaction Classification

Side effects are categorized by frequency, reflecting observations from clinical trials:

Classification Examples of Effects (System-Organ Class)
Very Common (ge 1/10) Erythema (redness), application site reactions.
Common (ge 1/100 to < 1/10) Pruritus (itching), rash, application site burning or pain.
Uncommon (ge 1/1,000 to < 1/100) Dizziness, skin lesion.
Very Rare (< 1/10,000) Anaphylactic or Hypersensitivity reactions.

Serious Adverse Reactions

The most critical adverse reactions documented in official labeling are associated with high systemic levels of the active ingredient. These serious reactions primarily involve the Nervous System and Cardiovascular System, and include Seizures, Cardiovascular Collapse, Severe Bradycardia, and Cardiac Arrest. A rare but serious blood condition, Methemoglobinemia, is also documented.

Population-Specific Safety Considerations

Official documents note specific safety considerations for certain patient groups. Individuals with Severe Hepatic Impairment may be at an increased risk of developing toxic blood concentrations due to altered metabolism. Infants, particularly those under six months, have an explicitly noted increased susceptibility to Methemoglobinemia. Additionally, older adults may exhibit increased sensitivity to systemic effects.

The product is contraindicated in individuals with known Hypersensitivity to the active ingredient or to other amide-type local anesthetics.

Overdose and Emergency Response

The regulatory information for Luan overdose focuses strictly on the risks associated with the systemic absorption of the active ingredient, Lidocaine Hydrochloride. Overdose, which is typically documented as resulting from excessive application or use over large or compromised skin areas, primarily affects the central nervous system (CNS) and the cardiovascular system (CVS).

Early documented manifestations of CNS toxicity include subjective signs such as tinnitus, dizziness, perioral numbness, and a metallic taste. If systemic toxicity progresses, more severe CNS effects may occur, including tremors, convulsions (seizures), and eventual respiratory depression or arrest.

The cardiovascular system can experience depressant effects, manifesting as bradycardia (slow heart rate), hypotension (low blood pressure), and the potential for cardiovascular collapse, leading to cardiac arrest. A rare, serious complication explicitly noted in regulatory documents is methemoglobinemia, which may present with cyanotic (blue or gray) skin discoloration.

Regulators mandate that individuals must seek immediate medical attention for any sign or symptom of systemic toxicity. Management, as defined in official prescribing information, involves symptomatic and supportive treatment, including close monitoring and maintaining a patent airway. The documentation notes that certain patient groups, including children and those with severe hepatic impairment, may be more sensitive to these systemic effects.

Therapeutic Uses of Luan

What Luan Treats: Main Uses and Benefits

Luan is a specialized topical preparation designed to support the management of acute discomfort by inducing temporary surface numbness. Its utility is centered on easing intense symptoms across specific surface pain and irritation domains.

The active ingredient is relevant for easing symptoms related to physical discomfort from certain skin conditions like scrapes, minor burns, and insect bites, which highlights its role in surface discomfort management.


Acute Localized Pain and Burning

This domain is used for managing symptoms related to physical discomfort, such as pain and intense localized sensations. It is applied across domains where additional symptomatic support is needed, for example, in conditions involving inflammatory or irritative states such as minor sunburn or abrasions. The therapeutic benefit provides support that helps ease the overall symptom burden by inducing temporary desensitization and contributes to improved day-to-day comfort when symptoms intensify.

Management of Intense Surface Itching

Luan is relevant in situations where symptoms cluster into patterns requiring supportive management, specifically severe, localized pruritus (itching). When applied, the medication may assist with managing symptoms related to physical discomfort, such as those that create noticeable physiological strain, and supports the patient during difficult episodes by easing distress.


Quick Fact: Relief for Acute Discomfort Luan is considered relevant in conditions involving episodic or fluctuating manifestations, often applied during phases when symptoms become more noticeable.

Regulatory References

  1. NIH DailyMed Drug Information

Eligibility and Restrictions for Use

Luan (prasterone) is a medication with official restrictions that strictly define the population eligible for its use, as documented by government regulatory agencies.

Eligibility and Exclusion

Classification Eligible or Excluded Population
Allowed Postmenopausal women only
Contraindicated Women with undiagnosed abnormal genital bleeding
Contraindicated Women with a known, suspected, or a history of breast cancer
Contraindicated Women with known or suspected estrogen-dependent malignant tumors
Contraindicated Patients with known hypersensitivity to prasterone or any ingredient
Not Indicated Pediatric patients (use and safety not established)
Not Indicated Pregnant or breastfeeding women

The drug is exclusively indicated for use in postmenopausal women, which formally excludes pediatric, male, and premenopausal or pregnant/lactating populations. Regulatory documents designate several absolute contraindications. Specifically, Luan must not be used by any woman experiencing undiagnosed, persistent, or recurring genital bleeding until a medical evaluation determines the cause. Furthermore, use is prohibited in women with a current or past diagnosis of breast cancer or any other estrogen-dependent cancer.

What should I know about interactions with other medicines?

Interactions with other medicines and products

This section summarizes officially documented interaction patterns for the active ingredient Lidocaine as reported in government regulatory documents.

Classification Interacting Agents or Conditions
Pharmacokinetic Interactions Co-administration with CYP1A2 and CYP3A4 Inhibitors (e.g., Cimetidine, Fluvoxamine, Propofol) is documented to reduce lidocaine clearance, potentially increasing systemic exposure. Concomitant use with Beta-adrenergic Blockers (e.g., Propranolol) may similarly increase plasma levels by decreasing hepatic blood flow.
Pharmacodynamic Interactions Co-administration with Class I Antiarrhythmic Drugs (e.g., Tocainide, Mexiletine) may result in additive and potentially synergistic toxic effects. Use with Oxidizing Agents (e.g., Nitrites) increases the documented risk of developing Methemoglobinemia.

The regulatory documents define the product’s interaction structure primarily through substances that reduce clearance and the risk of additive systemic toxicity with other agents affecting cardiac or sensory systems. The use of external heat sources (such as heating pads) on the application site is an interaction-related restriction, as it may increase drug exposure and risk of overexposure. For use in the mouth or throat area, food or chewing gum must not be ingested for at least one hour following application due to the potential for impaired swallowing. Additionally, patients with severe hepatic disease are cited in official labeling as a population with a heightened risk of drug accumulation and interaction-related toxicity due to reduced metabolic clearance.

Mechanism of Action

How Luan Works at the Biological and Physiological Level

Molecular Action: Modulating Cyclic Nucleotide Signaling

Luan (Papaverine) primarily works as a non-selective inhibitor of Phosphodiesterase (PDE) enzymes, targeting isoforms such as PDE4 B in smooth muscle tissue. This interaction prevents the hydrolysis of the second messenger cyclic Adenosine Monophosphate (cAMP), leading to increased intracellular concentrations.

Cellular Cascade: Affecting Calcium Homeostasis and Muscle Tone

The elevated cAMP activates Protein Kinase A (PKA), which initiates a molecular cascade resulting in the sequestration of free intracellular calcium ions (Ca^2+). The resultant altered intracellular calcium ion levels and modified smooth muscle contractile machinery directly contribute to a change in smooth muscle tone across various visceral and vascular beds.

Systemic Effect: Altering Vascular Resistance

The reduction in tone within the vascular smooth muscle walls results in peripheral vasodilation—a widening of the vessels. This change subsequently leads to altered vascular resistance and a modification of regional blood flow dynamics.

Dosage and Administration Information

How to Use Luan

Luan (Lidocaine Hydrochloride topical spray solution) is intended for external use only. Its usage is defined by specific parameters concerning the route, applied quantity, and frequency of application.


Administration Guidelines

Feature Description
Route of Administration Application is strictly Topical (Cutaneous), designated for external use only and not for injection or internal consumption.
Dosing Pattern The dose applied is generally the lowest quantity necessary to achieve the desired localized effect, spread evenly over the target surface.
Frequency Use is typically limited to a maximum of three to four applications daily.
Administration Context The spray is applied only to intact skin and not to raw, blistered, or otherwise compromised surfaces. Contact with sensitive areas, such as the eyes, must be strictly avoided.

Usage Structure and Limitations

The pattern of use for this preparation is as-needed and restricted to temporary, symptomatic relief. If the underlying condition persists beyond a short, specified duration (such as seven days), application is typically discontinued. Reduced doses are generally associated with specific patient groups, including the elderly and acutely ill, to align administration with their physical status. Standardized application ensures control over the amount and surface area of the dose.

Recent Clinical Evidence

Research evidence / Overview of studies for Luan


Evidence for Localized Surface Pain Relief

The core research for topical lidocaine, the active ingredient in Luan, has utilized Randomized Controlled Trials (RCTs) to explore the measurement of patient-reported outcomes related to physical discomfort from minor surface issues. These studies examined outcomes related to physical discomfort immediately following application. Researchers typically included adults and older children presenting with acute, localized superficial irritation, and monitored their perceived discomfort.

Studies monitored pain intensity ratings and described patterns related to changes in sensation following application. The research highlights changes measured during the study period, focusing on the initial short-term window following application. Long-term effects are not fully established, as research is ongoing and primarily focused on short-term symptom changes.


Evidence for Managing Intense Surface Itching (Pruritus)

Topical lidocaine was studied for its potential use in relieving intense, localized pruritus (itching). This research involved smaller-scale, controlled trials where outcomes related to physical discomfort were relevant in trials assessing short-term or episodic symptom patterns. The research describes that in some observed populations, studies monitored changes in reported itching intensity following application.

Evidence quality varies across studies, and the data specifically for anti-pruritic use are generally less voluminous and evidence is limited when compared to the studies on pain relief. Data for certain groups remain insufficient, and research exploring short-term symptom changes does not provide insight into more chronic or recurrent itching patterns.


Evidence for Cutaneous Numbing for Minor Procedures

The research explored the evidence base for topical lidocaine in relation to localized numbing before minor medical or dermatological interventions relies heavily on Randomized Controlled Trials (RCTs). This research was evaluated in settings where achieving a predictable, measured numbing effect was the primary goal. Studies explored specific outcomes such as the time needed to reach adequate numbing and the level of procedural discomfort reported by participants.

These studies report how symptoms evolved in the observed populations, consistently reporting the measurement of localized cutaneous anesthesia observed during minor procedural interventions. The research describes the patterns of onset time with high clarity, detailing the time points at which the numbing effect was measured in these controlled settings.

Frequently Asked Questions (FAQ)

Common questions about Luan (FAQ)

Q: What is the main reason Luan is prescribed, according to the official drug label?

The official purpose, as stated in regulatory documents, is based on the active ingredient Lidocaine, which is a local anesthetic. It is indicated for the production of topical anesthesia, meaning the temporary loss of feeling. The primary function is to provide temporary relief of minor pain.

Q: Is Luan something you have to take forever, or is it for short-term use?

Official instructions state that the use of Luan is generally restricted to temporary, symptomatic relief. Regulatory guidelines establish its role as a short-term treatment. If the condition for which it is being used persists beyond a short, specified duration, such as seven days, stopping the application is generally advised.

Q: How long does it typically take to notice any changes after starting Luan?

Official information does not generally provide a set time for the duration of effect for the topical solution. However, the effects of local anesthetics, such as the active ingredient Lidocaine, are usually noted shortly after application.

Q: Are there any common foods or drinks that should be avoided when taking Luan?

Regulatory documents specify a restriction concerning use in the mouth or throat area. If Luan is applied there, it is directed that food and chewing gum be avoided for at least one hour afterward because the product can impair swallowing. For external topical use, no general food or drink restrictions are noted in the official labeling.

Q: Is it common to feel tired or dizzy when taking Luan?

Drowsiness, dizziness, tiredness, and lightheadedness are listed in regulatory documents as potential side effects. These effects may be signs of systemic exposure to the active ingredients and occurrence can vary widely among patients.

Q: What kind of mental changes are listed as possible side effects of Luan?

Official documents list potential central nervous system (CNS) effects that could result from the active ingredients. These mental changes can include restlessness, anxiety, depression, confusion, and tremors. These are considered possible early signs of toxicity.

Q: Is Luan available in different strengths or forms?

Luan is officially marketed as a topical spray solution. While other forms and strengths of the active ingredients exist as separate products, the Luan product itself is described as this specific topical solution.

Q: Can Luan affect my ability to drive or operate machinery?

Because the active ingredients are associated with potential side effects such as dizziness and drowsiness, caution is generally recommended. It is generally advised that activities requiring mental alertness, such as driving or operating machinery, be avoided until the effect of the medication is known.

Q: Are there specific times of day that are recommended for taking Luan?

The regulatory texts state that Luan is for as-needed use. Official guidelines define the maximum application frequency as three to four times daily. Official documents do not mandate a specific time of day for when the product should be used.

Q: Are there any specific laboratory tests that need to be done while on Luan?

Regulatory documents state that for patients with a history of liver disease, regular monitoring of liver function tests may be recommended. This is due to the way the body processes the active ingredients, as reduced liver function can increase exposure risk.

Q: What age group is Luan generally approved for?

Regulatory information indicates that consultation with a healthcare provider is appropriate for patients who are 12 years and younger. Specific instructions are detailed for acutely ill patients and the elderly, who often require reduced doses. Extreme caution is also advised for children under 3 years of age.

Q: Can Luan be taken during pregnancy?

The active ingredient Lidocaine is categorized as Pregnancy Category B by some regulatory bodies. This classification means its use is defined by a standard where the potential benefit must be judged to outweigh the potential risk.

Q: Is Luan known to pass into breast milk?

Official documents indicate that the active ingredient Lidocaine is known to be excreted into human milk in small amounts. Caution is noted in regulatory information, and guidance from a health professional is typically sought if considering use while breastfeeding.

Q: Where can I find the official patient leaflet for Luan?

The product is required to come with a patient information and instructions leaflet when dispensed. Additionally, official drug labeling and information can be found on government websites that host drug regulatory information, such as DailyMed.

Q: Is there a risk of becoming dependent on Luan?

Regulatory literature reports that drug dependence resulting from the abuse of certain depressants, including Papaverine (one of the active ingredients), has been reported.

Q: Does Luan require a special prescription?

The prescription status of the product depends on the specific formulation and strength. While some similar topical solutions containing Lidocaine are designated 'Rx only' (prescription only), the exact status depends on the specific product and its regulatory approval.

Q: How should Luan be stored?

The product is classified as extremely flammable. Regulatory storage instructions prohibit use near heat or open flame due to flammability. The product is also directed to be stored away from high temperatures, generally not exceeding 104 F (40 C).

Q: Can Luan affect blood pressure readings?

The active ingredients in Luan are known to interact with the cardiovascular system. Official documents indicate that Lidocaine can cause changes in cardiac output and total peripheral resistance, which may result in altered blood pressure.

Q: What specific ingredients are in Luan besides the active one?

Official labeling lists inactive ingredients, which are necessary for the spray solution formulation. These may include common substances such as Propylene Glycol and Alcohol.

Q: Are headaches a common initial side effect of Luan?

Headaches are listed in the regulatory documents as a potential side effect associated with one of the active ingredients, Papaverine. Side effect occurrence can vary widely among patients.

Q: Does Luan affect mood or energy levels?

Official documents associate the active ingredients with effects on the central nervous system. These effects may include potential for anxiety, depression, drowsiness, and unusual tiredness, which could influence overall mood and energy.

Q: Can I use Luan if I am trying to conceive?

Official literature indicates that there is no evidence that the active ingredient Lidocaine affects fertility. However, official literature notes that guidance from a health professional is typically sought regarding medication use when trying to conceive.

Q: Are there specific warnings about Luan for teenagers?

Regulatory information indicates that reduced doses are appropriate for patients who are debilitated or acutely ill, commensurate with their age and physical status. Specific warnings for adolescents are typically covered under the general precautions for the patient population.

Q: Does Luan cause dry mouth or changes in appetite?

Dry mouth, decreased appetite (anorexia), and other gastrointestinal side effects are listed in regulatory documents as potential effects associated with the active ingredients.

Q: What is the official medical classification of the drug Luan?

Luan contains two active components. Lidocaine is classified as a local anesthetic, and Papaverine is classified as a peripheral vasodilator and smooth muscle relaxant, which works by inhibiting certain enzymes.

Q: What is the difference between the brand name Luan and its generic name?

Luan is the registered brand name for the product. Its active ingredients are Lidocaine and Papaverine, which are the generic names for the specific substances responsible for the product's effects.

Q: What are the main contraindications for using Luan?

Official documents describe several instances where use of Luan is contraindicated. This includes patients with a known hypersensitivity (severe allergic reaction) to local anesthetics of the amide-type or those with severe pre-existing conditions like heart block. Caution is also advised when patients have severe shock or severe liver disease.

Q: Why is Luan not recommended for people with certain heart conditions?

Luan is generally not recommended for people with certain pre-existing conditions, such as complete atrioventricular heart block or severe shock. Patients with impaired cardiovascular function may also be less able to compensate for functional changes caused by the medicine, according to official warnings.

How should Luan be stored and disposed of?

The official regulatory documentation for Luan (Lidocaine Cutaneous Spray) mandates specific conditions to ensure product integrity and safety.

Storage Requirements

Condition Regulatory Requirement
Temperature Store at Controlled Room Temperature, 20 to 25 C (68 to 77 F). Do not store above 40 C (104 F) [DailyMed].
Protection Keep out of direct sunlight and away from excessive heat or open flame, as the product is Extremely Flammable. Do not freeze [DailyMed].
Container The container is pressurized and must not be punctured or incinerated [FDA]. Store in the original container.
Child Safety Keep out of the sight and reach of children. The container must be kept tightly closed and secured immediately after use [FDA, NIH].

Disposal Instructions

Official disposal is preferentially handled via a drug take-back program. If this is unavailable, unused medicine can be disposed of in household trash by mixing it with an undesirable substance (e.g., dirt, coffee grounds) and placing it in a sealed container [FDA]. Consult local waste authorities for specific disposal of the pressurized aerosol container.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Luan found in:

A-Z Index: